259729-92-5Relevant academic research and scientific papers
USE OF (S)-DIDESMETHYLSIBUTRAMINEFOR TREATING, PREVENTING AND MANAGING A SLEEP DISORDER
-
Page/Page column 29-30, (2008/06/13)
This invention relates, in part, to methods of treating, preventing and/or managing a sleep disorder using enantiomerically pure (S)-didesmethylsibutramine, or a pharmaceutically acceptable salt, hydrate, solvate, clathrate or prodrug thereof. Specific me
DOPAMINE-AGONIST COMBINATION THERAPY FOR IMPROVING SLEEP QUALITY
-
Page/Page column 69-70, (2008/06/13)
The present invention generally to pharmaceutical compositions comprising a dopamine agonist and sedative agent. In a preferred embodiment, the dopamine agonist is optically pure (S)-didesmethylsibutramine. In a preferred embodiment, the sedative agent is
